106 related articles for article (PubMed ID: 35198101)
21. Gene Therapy for Hepatocellular Carcinoma Using Adenoviral Vectors Delivering a Gene Encoding IL-17A-Neutralizing Antibody Fragments.
Zou H; Tuhin IJ; Monty MA; Luo S; Shao J; Yan Z; Yu L
Hum Gene Ther; 2020 Oct; 31(19-20):1074-1085. PubMed ID: 32390483
[TBL] [Abstract][Full Text] [Related]
22. A study on the inhibitory effect of Solanum lyratum Thunb extract on Lewis lung carcinoma lines.
Xiao ZM; Wang AM; Wang XY; Shen SR
Afr J Tradit Complement Altern Med; 2013; 10(6):444-8. PubMed ID: 24311865
[TBL] [Abstract][Full Text] [Related]
23. Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas.
Dawod B; Liu J; Gebremeskel S; Yan C; Sappong A; Johnston B; Hoskin DW; Marshall JS; Wang J
Sci Rep; 2020 Aug; 10(1):13343. PubMed ID: 32770025
[TBL] [Abstract][Full Text] [Related]
24. Dynamically expressed microRNA-15b modulates the activities of CD8+ T lymphocytes in mice with Lewis lung carcinoma.
Zhong G; Cheng X; Long H; He L; Qi W; Xiang T; Zhao Z; Zhu B
J Transl Med; 2013 Mar; 11():71. PubMed ID: 23517578
[TBL] [Abstract][Full Text] [Related]
25. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8
Zhang Md J; Zhang Md L; Yang Md Y; Liu Md Q; Ma Md H; Huang Md A; Zhao Md Y; Xia Md Z; Liu Md T; Wu Md G
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1533-1546. PubMed ID: 33238192
[TBL] [Abstract][Full Text] [Related]
26. IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer.
Andersson A; Yang SC; Huang M; Zhu L; Kar UK; Batra RK; Elashoff D; Strieter RM; Dubinett SM; Sharma S
J Immunol; 2009 Jun; 182(11):6951-8. PubMed ID: 19454692
[TBL] [Abstract][Full Text] [Related]
27. Immune regulation effect of lienal polypeptides extract in Lewis lung carcinoma-bearing mice treated with cyclophosphamide.
Wu YP; Deng J; Ouyang SH; Mao ZF; Wang GE; Kurihara H; He RR; Li YF
Exp Biol Med (Maywood); 2018 Jan; 243(1):66-77. PubMed ID: 29078731
[TBL] [Abstract][Full Text] [Related]
28. Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.
Chung S; Kijima K; Kudo A; Fujisawa Y; Harada Y; Taira A; Takamatsu N; Miyamoto T; Matsuo Y; Nakamura Y
Oncotarget; 2020 Oct; 11(41):3749-3750. PubMed ID: 33110482
[TBL] [Abstract][Full Text] [Related]
29. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
[TBL] [Abstract][Full Text] [Related]
30. [Compound K suppresses myeloid-derived suppressor cells in a mouse model bearing CT26 colorectal cancer xenograft].
Wang R; Li Y; Wang W; Zhou M; Cao Z
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):748-52. PubMed ID: 26018276
[TBL] [Abstract][Full Text] [Related]
31. Correction: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma.
Boulos S; Park MC; Zeibak M; Foo SY; Jeon YK; Kim YT; Motzik A; Tshori S; Hamburger T; Kim S; Nechushtan H; Razin E
Oncotarget; 2018 Nov; 9(90):36250. PubMed ID: 30546840
[TBL] [Abstract][Full Text] [Related]
32. Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR.
Liu X; Yin M; Dong J; Mao G; Min W; Kuang Z; Yang P; Liu L; Zhang N; Deng H
Acta Pharm Sin B; 2021 Oct; 11(10):3134-3149. PubMed ID: 34745852
[TBL] [Abstract][Full Text] [Related]
33. [Ethanol extract of Rhodiola rosea L. regulates the number of tumor infiltrating T cells to enhance antitumor effect in Lewis lung cancer-bearing mice].
Zhang Y; Zhang X; Yue Q; Wen Z; Zhang M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Feb; 35(2):103-108. PubMed ID: 30975273
[TBL] [Abstract][Full Text] [Related]
34. Water extract from Euglena gracilis prevents lung carcinoma growth in mice by attenuation of the myeloid-derived cell population.
Ishiguro S; Upreti D; Robben N; Burghart R; Loyd M; Ogun D; Le T; Delzeit J; Nakashima A; Thakkar R; Nakashima A; Suzuki K; Comer J; Tamura M
Biomed Pharmacother; 2020 Jul; 127():110166. PubMed ID: 32361165
[TBL] [Abstract][Full Text] [Related]
35. Antitumor and other effects of 24R,25-dihydroxycholecalciferol in Lewis lung carcinoma causing abnormal calcium metabolism in tumor-bearing mice.
Maeda Y; Yamato H; Hirai T; Kobori N; Fujii T; Kobayashi Y; Saitoh K; Inoguchi E; Hakozaki M; Iijima H
Oncology; 1988; 45(3):202-5. PubMed ID: 3368196
[TBL] [Abstract][Full Text] [Related]
36. CD205
Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
[TBL] [Abstract][Full Text] [Related]
37. Correction: Quinacrine inhibits GSTA1 activity and induces apoptosis through G
Kumar M; Martin A; Nirgude S; Chaudhary B; Mondal S; Sarkar A
Oncotarget; 2020 Nov; 11(46):4364-4365. PubMed ID: 33245730
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity and immunomodulatory effects of the intraperitoneal administration of Kanglaite in vivo in Lewis lung carcinoma.
Pan P; Wu Y; Guo ZY; Wang R; Wang YJ; Yuan YF
J Ethnopharmacol; 2012 Sep; 143(2):680-5. PubMed ID: 22867634
[TBL] [Abstract][Full Text] [Related]
39. Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.
Gravina GL; Mancini A; Colapietro A; Marampon F; Sferra R; Pompili S; Biordi LA; Iorio R; Flati V; Argueta C; Landesman Y; Kauffman M; Shacham S; Festuccia C
Oncotarget; 2019 Oct; 10(59):6393-6395. PubMed ID: 31695847
[TBL] [Abstract][Full Text] [Related]
40. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis.
Jian SL; Chen WW; Su YC; Su YW; Chuang TH; Hsu SC; Huang LR
Cell Death Dis; 2017 May; 8(5):e2779. PubMed ID: 28492541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
